Waypoint Orthopedics Submits 510(k) Application for Waypoint GPS™
July 15, 2022 08:00 ET
|
Waypoint Orthopedics, Inc.
MALVERN, Pa., July 15, 2022 (GLOBE NEWSWIRE) -- Waypoint Orthopedics, Inc., a spinal instrumentation company, announced the company's recent submission of an FDA 510(k) application for the Waypoint...
Conformis, Inc. Announces 510(k) Clearance for Identity Imprint™ Knee Replacement System
May 10, 2021 07:30 ET
|
Conformis, Inc.
BILLERICA, Mass., May 10, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) today announced 510(k) clearance by the U.S. Food and Drug Administration for the Company’s Identity Imprint Knee...
Biotricity Provides Quarter Update and Announces Continued Growth
September 01, 2020 08:00 ET
|
biotricity
REDWOOD CITY, Calif., Sept. 01, 2020 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company, today announced record results in its...
BioElectronics Announces Withdrawal and Planned Resubmission of 510(k) for General Musculoskeletal Pain
May 22, 2019 10:43 ET
|
BioElectronics Corporation
FREDERICK, MD, May 22, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioElectronics Corporation (OTC PINK: BIEL) www.bielcorp.com, the maker of non-invasive electroceutical devices, announced today...
BioSig Technologies Issues 2018 Shareholder Letter
April 05, 2018 08:00 ET
|
BioSig Technologies, Inc.
Santa Monica, CA, April 05, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (BSGM) a medical device company developing a proprietary biomedical signal processing platform designed to address an...
BioSig Announces Submission of FDA 510(k) Application for PURE EP System
March 28, 2018 08:00 ET
|
BioSig Technologies, Inc.
Santa Monica, CA, March 28, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM) announced that the Company has filed 510(k) application to the U.S. Food and Drug Administration (FDA)...
BioSig Announces Submission of FDA 510(k) Application for PURE EP™ System
March 28, 2018 02:00 ET
|
BioSig Technologies, Inc.
SANTA MONICA, Calif., March 28, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB:BSGM) announced that the Company has filed 510(k) application to the U.S. Food and Drug Administration (FDA)...
Biotricity Achieves FDA 510(k) Clearance for its Bioflux Device
December 18, 2017 08:00 ET
|
biotricity
REDWOOD CITY, Calif., Dec. 18, 2017 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric...
BioSig Technologies Adds Role of Chief Regulatory and Compliance Officer in Preparation for FDA Submission
November 14, 2017 08:00 ET
|
BioSig Technologies, Inc.
Santa Monica, CA, Nov. 14, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to...
Renowned Cardiologist Dr. Rony Shimony Joins Biotricity Board of Advisors
November 01, 2016 08:00 ET
|
biotricity
REDWOOD CITY, Calif., Nov. 01, 2016 (GLOBE NEWSWIRE) -- biotricity, Inc. (OTCQB:BTCY), a healthcare technology company dedicated to delivering innovative, medically relevant biometric remote...